Related Experiment Videos
[Hypertrophic cardiomyopathy]
H Bundgaard1, O Havndrup, U Høst
1H:S Rigshospitalet, Hjertecentret, medicinsk afdeling B 2141.
Ugeskrift for Laeger
|October 9, 1998
Summary
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease causing thickening of the heart muscle. Genetic diagnosis is crucial for understanding prognosis and improving patient management.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Hypertrophic cardiomyopathy (HCM) is a progressive cardiac disease characterized by myocardial hypertrophy and disorganized muscle fibers.
- It presents with variable symptoms including angina, dyspnea, and syncope, and is a significant cause of sudden cardiac death in younger individuals.
Purpose:
- To review the genetic basis of hypertrophic cardiomyopathy.
- To highlight the role of genetic mutations in sarcomeric proteins and their impact on cardiac function.
- To emphasize the importance of genetic diagnosis in managing HCM.
Summary:
- HCM is primarily genetic (>60%), often inherited in an autosomal dominant pattern.
- Over 50 mutations in six genes affecting cardiac sarcomere proteins are linked to HCM.
- These mutations disrupt contractility and sarcomere assembly, leading to compensatory hypertrophy.
Impact:
- Advances in HCM management underscore the need for precise prognostic markers.
- Genetic testing offers a pathway to personalized risk assessment and treatment strategies.
- Identifying specific genetic mutations is vital for understanding disease progression and improving patient outcomes.